SecBot SecBot
3 ·Filed Aug 12, 2026

MLYS

Mineralys Therapeutics, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed3mo ago SEC0001933414-26-000119
Form 3, initial insider ownership statement
Actionable Insight • Neutral

This is a routine Form 3 filing for a new officer. No trading signal or material event. Monitor for future Form 4 filings that may disclose insider transactions.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$26.09
T+0 close · Aug 12, 2026 · via day close
Latest settled
−41.24%
T+60 · $15.33
Vs SPY
−35.77%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Aug 13 $26.09entry
  2. T+1 · 3mo ago −1.72%α −1.53% · $25.64
  3. T+5 · 3mo ago −1.30%α +0.66% · $25.75
  4. T+20 · 2mo ago +8.09%α +9.83% · $28.20
  5. T+60 · 11d ago −41.24%α −35.77% · $15.33

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

James J. Ferguson III filed an initial statement of beneficial ownership (Form 3) with the SEC, disclosing his appointment as Chief Medical Officer of Mineralys Therapeutics. The filing is a routine administrative requirement for new officers and contains no financial data, trading activity, or material corporate events.

Key Facts

  • James J. Ferguson III filed a Form 3 as a new reporting owner of Mineralys Therapeutics.
  • Ferguson is listed as Chief Medical Officer of the company.
  • The filing includes a Power of Attorney authorizing others to file Section 16 reports on his behalf.
  • No beneficial ownership amounts or securities transactions are disclosed in the filing.

Financial Impact

No financial impact, the filing is an initial ownership statement with no disclosed holdings or transactions.

Risk Factors

  • No material risks identified from this filing.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
88% bullish (16 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
3 Filing (Primary)0001933414-26-000119
Document: 0001933414-26-000119-index-headers.html0001933414-26-000119
Document: 0001933414-26-000119-index.html0001933414-26-000119
Document: 0001933414-26-000119.txt0001933414-26-000119

Track record

35 reports on MLYS

Performance horizon

4 of 7 bullish or bearish reports moved the stock their way by T+20. Best: +20.97% at T+20 after the Jun 11, 2026 report. 5 of 10 went positive at some point.

Filters
  1. Nov 8, 20268d ago Press Release Bullish 6/10 Entry $15.81 Now $14.53 −8.10% settles Dec 8
  2. Nov 4, 202612d ago 8-K Neutral 4/10 Entry $15.24 Now $14.53 −4.66% settles Dec 4
  3. Nov 3, 202613d ago Institutional Cluster Neutral 2/10 Entry $15.99 Now $14.53 −9.13% settles Dec 2
  4. Oct 29, 202618d ago 8-K Bullish 6/10 Entry $18.18 Now $14.53 −20.08% settles Nov 30
  5. Oct 28, 202619d ago Press Release Bullish 6/10 Entry $21.38 Now $14.53 −32.04% settles Nov 25
  6. Oct 20, 202627d ago 3 Neutral 2/10 Entry $21.10 Now $14.53 −31.14% settles Nov 18
  7. Oct 20, 202627d ago 3 Neutral 2/10 Entry $21.10 Now $14.53 −31.14% settles Nov 18
  8. Oct 19, 202628d ago 8-K Neutral 2/10 Entry $21.58 Now $14.53 −32.67% settles Nov 17
  9. Oct 13, 20264w ago 144 Neutral 3/10 Entry $20.76 to $16.16 Now $14.53 −30.01% ▼ −22.16% −20.89% vs SPY
  10. Sep 30, 20266w ago 144 Neutral 3/10 Entry $23.72 to $21.24 Now $14.53 −38.74% ▼ −10.46% −11.16% vs SPY
Showing 10 of 35

US Market Status

Market Closed · Opens in 8h 59m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 12, 2026